estriol has been researched along with Hematologic Malignancies in 1 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stangel-Wojcikiewicz, K | 1 |
| Zdebik, A | 1 |
| Jach, R | 1 |
| Huras, H | 1 |
| Wadowska-Jaszczynska, K | 1 |
| Radon-Pokracka, M | 1 |
| Kempisty-Zdebik, E | 1 |
| Ludwin, A | 1 |
| Ludwin, I | 1 |
1 other study available for estriol and Hematologic Malignancies
| Article | Year |
|---|---|
Hormone replacement therapy regimens in chemotherapy-induced premature ovarian failure and the subsequent correction of hormone levels.
Topics: Adolescent; Adult; Chemoradiotherapy; Contraceptive Agents, Female; Drug Combinations; Dydrogesteron | 2012 |